LENZ - LENZ Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$12.00
DETAILS
HIGH:
$12.00
LOW:
$12.00
MEDIAN:
$12.00
CONSENSUS:
$12.00
UPSIDE:
118.98%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Wood | 0 | $0 | -- | -- | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-06-15 | MCCOLLUM JAMES W | director | A-Award | 22,100 | $6.63 | $147K |
| 2026-06-15 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | A-Award | 22,100 | $6.63 | $147K |
| 2026-06-15 | George Jeffrey P. | director | A-Award | 22,100 | $6.63 | $147K |
| 2026-06-15 | Drapkin Kimberlee C | director | A-Award | 22,100 | $6.63 | $147K |
| 2026-06-15 | Thunen Shelley B | director | A-Award | 22,100 | $6.63 | $147K |
| 2026-06-15 | Guerard Frederic | director | A-Award | 22,100 | $6.63 | $147K |
| 2026-06-15 | Scheiner Zachary | director | A-Award | 22,100 | $6.63 | $147K |
| 2026-03-27 | Chevallard Daniel R. | officer: Chief Financial Officer | BUY | 7,500 | $8.57 | $64K |
| 2026-03-27 | George Jeffrey P. | director | BUY | 5,592 | $8.92 | $50K |
| 2026-03-27 | Schimmelpennink Evert B. | director, officer: President, CEO and Secretary | BUY | 28,089 | $8.95 | $251K |
| 2026-01-02 | Olsson Shawn | officer: Chief Commercial Officer | A-Award | 14,000 | -- | -- |
| 2026-01-02 | Odrich Marc | officer: Chief Medical Officer | A-Award | 84,200 | $16.00 | $1.3M |
| 2026-01-02 | Odrich Marc | officer: Chief Medical Officer | A-Award | 14,000 | -- | -- |
| 2026-01-02 | Olsson Shawn | officer: Chief Commercial Officer | A-Award | 84,200 | $16.00 | $1.3M |
| 2026-01-02 | Chevallard Daniel R. | officer: Chief Financial Officer | A-Award | 84,200 | $16.00 | $1.3M |
| 2026-01-02 | Chevallard Daniel R. | officer: Chief Financial Officer | A-Award | 14,000 | -- | -- |
| 2026-01-02 | Schimmelpennink Evert B. | director, officer: President, CEO and Secretary | A-Award | 358,100 | $16.00 | $5.7M |
| 2025-11-17 | Olsson Shawn | officer: Chief Commercial Officer | M-Exempt | 10,000 | $2.08 | $21K |
| 2025-11-17 | Olsson Shawn | officer: Chief Commercial Officer | SELL | 4,212 | $25.74 | $108K |
| 2025-11-17 | Olsson Shawn | officer: Chief Commercial Officer | SELL | 5,788 | $26.37 | $153K |
| 2025-11-07 | MCCOLLUM JAMES W | director | BUY | 10,500 | $22.79 | $239K |
| 2025-11-07 | Chevallard Daniel R. | officer: Chief Financial Officer | BUY | 2,178 | $22.76 | $50K |
| 2025-11-07 | Chevallard Daniel R. | officer: Chief Financial Officer | BUY | 20 | $22.71 | $454 |
| 2025-09-30 | Versant Venture Capital VI, L.P. | 10 percent owner | SELL | 83,066 | $46.41 | $3.9M |
| 2025-09-30 | Versant Venture Capital VI, L.P. | 10 percent owner | SELL | 49,701 | $45.35 | $2.3M |